FundedIQ
Biotechnology

OMass Technologies: Funding, Investors & Team (Oct 2026)

OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.

omass.com LinkedIn Oxford, United Kingdom 11-50 employees
Life Science Pharmaceutical
Total raised
$107M
Rounds
2
Latest
Series B
May 2023

OMass Technologies has raised $107M across 2 funding rounds on record, the most recent a Series B of $12.5M announced in May 2023.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

OMass Technologies Company Profile and Key Stats

Total funding raised
$107M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series B
$12.5M in May 2023
Employees
11-50
reported band
Headquarters
Oxford, United Kingdom

Latest funding round on record: May 2023.

OMass Technologies Funding Rounds

Date
Round
Amount
Series B
$12.5M
Series B
$94.8M

OMass Technologies raised $94.8M in a Series B announced in Apr 2022.

1.1 years later, a Series B of $12.5M was announced in May 2023.

OMass Technologies Founders and Leadership Team

Name
Role
Contact
Hsin Yung Yen
Founder
—
Idlir Liko
Founder
—

No contact details are on record for this team yet.

OMass Technologies Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
5,352
$4.1M
4,401
$31M

OMass Technologies' latest round of $12.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like OMass Technologies in Biotechnology and Oxford

Companies Similar to OMass Technologies

R1 Therapeutics is a clinical‑stage biopharmaceutical company focused on discovering and developing new drug…

Series A $3.0M

The perfect package for any general surgical trainee or resident. Progress from beginner to advanced surgical…

Undisclosed round $9.3M

Argonaute RNA company research projects build on existing intellectual property.

Undisclosed round $1.8M

An innovative C elegans company that serves the biotech, nutrition, and other industries and fields of study…

Undisclosed round $1.8M

ViaNautis, previously known as SomaServe, was established in 2018 as a separate entity from UCL under the…

Undisclosed round $23.3M

Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…

Series A $33.6M

Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…

Undisclosed round $3.5M

Concert Bio helps businesses create optimal microbial communities.

Undisclosed round $130k

RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…

Series A $113M

N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…

Undisclosed round $3.6M

Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…

Undisclosed round $3.0M

Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.

Series A $32.5M

OMass Technologies Funding FAQs

What does OMass Technologies do?

OMass Technologies is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics against challenging disease targets.

How much funding has OMass Technologies raised?

OMass Technologies has raised $107M across 2 rounds on record. The most recent is a Series B of $12.5M announced in May 2023.

When did OMass Technologies last raise funding?

OMass Technologies' most recent funding round on record is a Series B of $12.5M, announced in May 2023.

Who founded OMass Technologies?

FundedIQ lists Hsin Yung Yen (Founder), Idlir Liko (Founder) at OMass Technologies.

Where is OMass Technologies headquartered?

OMass Technologies is based in Oxford, Oxfordshire, United Kingdom.

How many employees does OMass Technologies have?

OMass Technologies is in the 11-50 employee band.

How does OMass Technologies' funding compare to other Biotechnology startups?

OMass Technologies' latest round of $12.5M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's OMass Technologies Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for OMass Technologies is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.